Lack of inducible nitric oxide synthase in bronchial epithelium: A possible mechanism of susceptibility to infection in cystic fibrosis

Journal of Pathology

Volumn 184, Issue 3, 1998, Pages 323-331

  Meng, Qing Hai ^a   Springall, David R ^a   Bishop, Anne E ^a   Morgan, Kevin ^a   Evans, Tom J ^a   Habib, Said ^b   Gruenert, Dieter C ^c   Gyi, Khin M ^d   Hodson, Margaret E ^d   Yacoub, Magdi H ^b   Polak, Julia M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAREFIELD HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Bronchial epithelium; Cystic fibrosis; Inducible nitric oxide synthase; Inflammation

Indexed keywords

CORTICOSTEROID; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BRONCHIECTASIS; BRONCHUS MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE PREDISPOSITION; ENZYME INDUCTION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; INHALATIONAL DRUG ADMINISTRATION; LUNG EMPHYSEMA; LUNG INFECTION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SECOND MESSENGER;

ADULT; BRONCHI; CELL CULTURE TECHNIQUES; CYSTIC FIBROSIS; CYTOKINES; EPITHELIUM; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0031913858     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199803)184:3<323::AID-PATH2>3.0.CO;2-2     Document Type: Article

References (41)

1. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066-1073.
2. Boat TF, Welsh MJ, Beaudet AL. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 6th edn. New York: McGraw-Hill, 1988; 2649-2680.
3. Welsh MJ, Fick BR. Cystic fibrosis. J Clin Invest 1987; 80: 1523-1526.
4. Riordan JR. The cystic fibrosis transmembrane conductance regulator. Annu Rev Physiol 1993; 55: 609-630.
5. Moncada S, Palmer RMJ, Higgs EA Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 48: 109-142.
6. Summersgill JT, Powell LA, Buster BL, Miller RD, Ramirez JA. Killing , of Legionella pneumophila by nitric oxide in gamma interferon-activated macrophages. J Leukoc Biol 1992; 52: 625-629.
7. Liew FY. The role of nitric oxide in parasitic diseases. Ann Trop Med Parasitol 1993; 87: 637-642.
8. Karupiah G, Xie Q-W, Buller RM, Nathan C, Duarte C, MacMicking JD. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 1993; 261: 1445-1448.
9. Quie PG. Lung defense against infection. J Pediatr 1986, 108: 813-816.
10. Diamond G, Russell JP, Bevins CL. Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells. Proc Natl Acad Sci USA 1996; 93: 5156-5160.
11. Russell JP, Diamond G, Tarver AP, Scanlin TF, Bevins CL. Coordinate induction of two antibiotic genes in tracheal epithelial cells exposed to the inflammatory mediators lipopolysaccharide and tumor necrosis factor alpha. Infect Immun 1996; 64: 1565-1568.
12. Smith JJ, Travis SM, Greenberg EP, Welsh MJ. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 1996; 85: 229-236.
13. Kobzik L, Bredt DS, Lowenstein CJ, et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 1993; 9: 371-377.
14. Robbins RA, Barnes PJ, Springall DR, et al. Expression of inducible nitric oxide in human lung epithelial cells. Biochem Biophys Res Commun 1994; 203: 209-218.
15. Guo FH, De-Raeve HR, Rice TW, Stuehr DJ, Thunnissen FB, Erzurum SC. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci USA 1995; 92: 7809-7813.
16. Asano K, Chee CB, Gaston B, et al, Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci USA 1994; 91: 10089-10093.
17. Hamid Q, Springall DR, Riveros-Moreno V, et al. Induction of nitric oxide synthase in asthma. Lancet 1993; 342: 1510-1513.
18. Warner RL, Paine R, Christensen PJ, et al. Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. Am J Respir Cell Mol Biol 1995; 12: 649-661.
19. Chu SC, Wu HP, Banks TC, Eissa NT, Moss J. Structural diversity in the 5′-untranslated region of cytokine-stimulated human inducible nitric oxide synthase mRNA. J Biol Chem 1995; 270: 10625-10630.
20. Kronborg G. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection. APMIS Suppl 1995; 50: 1-30.
21. Schuster A, Haarmann A, Wahn V. Cytokines in neutrophildominated airway inflammation in patients with cystic fibrosis. Eur Arch Otorhinolaryngol 1995; 1: S59-S60.
22. Bonfield TL, Panuska JR, Konstan MW, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995; 152: 2111-2118.
23. Springall DR, Riveros-Moreno V, Buttery LDK, et al. Immunological detection of nitric oxide synthase(s) in human tissues using heterologous antibodies suggesting different isoforms. Histochemistry 1992; 98: 259-266.
24. Geller DA, Lowenstein CJ, Shapiro RA, et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 1993; 90: 3491-3495.
25. Evans TJ, Buttery LDK, Carpenter A, Springall DR, Polak JM, Cohen J. Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. Proc Natl Acad Sci USA 1996; 93: 9553-9558.
26. Buttery LDK, Chester AH, Springall DR, et al. Explanted vein grafts with an intact endothelium demonstrate reduced focal expression of endothelial NO synthase specific to atherosclerotic sites. J Pathol 1996; 179: 197-203.
27. Haws C, Krouse ME, Xia Y, Gruenert DC, Wine JJ. CFTR channels in immortalized human airway cells. Am J Physiol 1992; 263: L692-L707/.
28. Cozens AL, Yezzi MJ, Kunzelmann K, et al. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 1994; 10: 38-47.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid euanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
30. Ercolani L, Florence B, Denaro M, Alexander M. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 1988; 263: 15335-15341.
31. Morgan K, Wharton J, Webb JC, et al. Co-expression of renn-angiotensin system component genes in human atrial tissue. J Hypertens 1994; 12: S11-S19.
32. Francoeur C, Denis M. Nitric oxide and interleukin-8 as inflammatory components of cystic fibrosis. Inflammation 1995; 19: 587-598.
33. Balfour-Lynn IM, Laverty A, Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child 1996; 75: 319-322.
34. Belvisi M, Barnes PJ, Larkin S, et al. Nitric oxide synthase activity is elevated in inflammatory lung disease in human. Eur J Pharmacol 1995; 283: 255-258.
35. Pier GB, Grout M, Zaidi TS, et al. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 1996; 271: 64-67.
36. Doring G. The role of neutrophil elastase in chronic inflammation. Am J Respir Crit Care Med 1994; 150: S114-S117.
37. Godkin AJ, De Belder AJ, Villa L, et al. Expression of nitric oxide synthase in ulcerative colitis. Eur J Clin Invest 1996; 26: 867-872.
38. Tsui L-C. The spectrum of cystic fibrosis mutations. Trends Genet 1992; 8: 392-398.
39. The Cystic Fibrosis Genetic Analysis Consortium. Worldwide survey of the delta signF508 mutation: report from the Cystic Fibrosis Genetic Analysis Consortium. Am J Hum Genet 1990: 47: 354-359.
40. Saiman L, Calcalano G, Gruenert D, Prince A. Comparison of adherence of Pseudomonas aeruginosa to respiratory epithelial cells from cystic fibrosis patients and healthy subjects. Infect Immun 1992; 60: 2808-2814.
41. Gottlieb RA, Dosanjh A. Mutant cystic fibrosis transmembrane conductance regulator inhibits acidification and apoptosis in C127 cells: possible relevance to cystic fibrosis. Proc Natl Acad Sci USA 1996; 93: 3587-3591.